{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Transgènes : Questions médicales les plus fréquentes",
"headline": "Transgènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Transgènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Transgènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gènes",
"url": "https://questionsmedicales.fr/mesh/D005796",
"about": {
"@type": "MedicalCondition",
"name": "Gènes",
"code": {
"@type": "MedicalCode",
"code": "D005796",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes-suicide transgéniques",
"alternateName": "Genes, Transgenic, Suicide",
"url": "https://questionsmedicales.fr/mesh/D041722",
"about": {
"@type": "MedicalCondition",
"name": "Gènes-suicide transgéniques",
"code": {
"@type": "MedicalCode",
"code": "D041722",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.825.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Transgènes",
"alternateName": "Transgenes",
"code": {
"@type": "MedicalCode",
"code": "D019076",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xia Wang",
"url": "https://questionsmedicales.fr/author/Xia%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Chongqing Engineering Research Center for Floriculture, Key Laboratory of Horticulture Science for Southern Mountainous Regions of Ministry of Education, College of Horticulture and Landscape Architecture, Southwest University, Chongqing 400715, China."
}
},
{
"@type": "Person",
"name": "Taichi Oguchi",
"url": "https://questionsmedicales.fr/author/Taichi%20Oguchi",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan."
}
},
{
"@type": "Person",
"name": "Yasir Hasan Siddique",
"url": "https://questionsmedicales.fr/author/Yasir%20Hasan%20Siddique",
"affiliation": {
"@type": "Organization",
"name": "Drosophila Transgenic Laboratory, Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University , Aligarh , Uttar Pradesh , India."
}
},
{
"@type": "Person",
"name": "Falaq Naz",
"url": "https://questionsmedicales.fr/author/Falaq%20Naz",
"affiliation": {
"@type": "Organization",
"name": "Drosophila Transgenic Laboratory, Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University , Aligarh , Uttar Pradesh , India."
}
},
{
"@type": "Person",
"name": "None Rahul",
"url": "https://questionsmedicales.fr/author/None%20Rahul",
"affiliation": {
"@type": "Organization",
"name": "Drosophila Transgenic Laboratory, Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University , Aligarh , Uttar Pradesh , India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An updated patent review of glutaminase inhibitors (2019-2022).",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36698323",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13543776.2023.2173573"
}
},
{
"@type": "ScholarlyArticle",
"name": "Papers and patents are becoming less disruptive over time.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36600070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-022-05543-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "An updated patent review on monoamine oxidase (MAO) inhibitors.",
"datePublished": "2022-06-09",
"url": "https://questionsmedicales.fr/article/35638744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13543776.2022.2083501"
}
},
{
"@type": "ScholarlyArticle",
"name": "Global drug diffusion and innovation with the medicines patent pool.",
"datePublished": "2022-08-14",
"url": "https://questionsmedicales.fr/article/36030748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jhealeco.2022.102671"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patent Claim Scope and Biosimilar Competition in the US and EU.",
"datePublished": "2024-10-22",
"url": "https://questionsmedicales.fr/article/39435915",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/jme.2024.133"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Transgènes",
"item": "https://questionsmedicales.fr/mesh/D019076"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Transgènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Transgènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Transgènes",
"description": "Comment détecte-t-on des transgènes dans un organisme ?\nQuels tests sont utilisés pour analyser les transgènes ?\nLes transgènes peuvent-ils être détectés dans les aliments ?\nQuelles méthodes sont utilisées pour le diagnostic des transgènes ?\nPeut-on identifier des transgènes dans des tissus humains ?",
"url": "https://questionsmedicales.fr/mesh/D019076?mesh_terms=Patents+as+Topic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Transgènes",
"description": "Quels symptômes peuvent résulter de l'expression de transgènes ?\nLes transgènes provoquent-ils des effets indésirables ?\nY a-t-il des symptômes associés aux aliments transgéniques ?\nLes transgènes peuvent-ils affecter la santé humaine ?\nQuels symptômes sont liés aux thérapies géniques ?",
"url": "https://questionsmedicales.fr/mesh/D019076?mesh_terms=Patents+as+Topic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Transgènes",
"description": "Comment prévenir les risques liés aux transgènes ?\nPeut-on éviter les aliments transgéniques ?\nQuelles mesures de sécurité sont prises pour les transgènes ?\nComment sensibiliser sur les transgènes ?\nLes organismes de réglementation surveillent-ils les transgènes ?",
"url": "https://questionsmedicales.fr/mesh/D019076?mesh_terms=Patents+as+Topic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Transgènes",
"description": "Comment les transgènes sont-ils utilisés en médecine ?\nLes transgènes peuvent-ils traiter des maladies ?\nQuels traitements utilisent des transgènes ?\nLes transgènes sont-ils utilisés en oncologie ?\nQuels sont les risques des traitements par transgènes ?",
"url": "https://questionsmedicales.fr/mesh/D019076?mesh_terms=Patents+as+Topic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Transgènes",
"description": "Quelles complications peuvent survenir avec les transgènes ?\nLes transgènes peuvent-ils causer des maladies ?\nY a-t-il des complications environnementales liées aux transgènes ?\nComment les transgènes affectent-ils la santé publique ?\nLes transgènes peuvent-ils affecter la reproduction ?",
"url": "https://questionsmedicales.fr/mesh/D019076?mesh_terms=Patents+as+Topic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Transgènes",
"description": "Quels facteurs augmentent les risques liés aux transgènes ?\nLes allergies sont-elles un facteur de risque pour les transgènes ?\nL'environnement joue-t-il un rôle dans les risques des transgènes ?\nLes antécédents médicaux influencent-ils les risques liés aux transgènes ?\nL'âge est-il un facteur de risque pour les effets des transgènes ?",
"url": "https://questionsmedicales.fr/mesh/D019076?mesh_terms=Patents+as+Topic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on des transgènes dans un organisme ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des techniques comme la PCR et le séquençage pour identifier les transgènes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les transgènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'analyse de l'ADN par électrophorèse et la hybridation."
}
},
{
"@type": "Question",
"name": "Les transgènes peuvent-ils être détectés dans les aliments ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests spécifiques peuvent identifier la présence de transgènes dans les aliments."
}
},
{
"@type": "Question",
"name": "Quelles méthodes sont utilisées pour le diagnostic des transgènes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes incluent la PCR quantitative et les tests de Southern blot."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des transgènes dans des tissus humains ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la PCR peuvent détecter des transgènes dans des échantillons de tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent résulter de l'expression de transgènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le transgène, mais peuvent inclure des réactions immunitaires."
}
},
{
"@type": "Question",
"name": "Les transgènes provoquent-ils des effets indésirables ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets indésirables peuvent survenir, comme des allergies ou des toxicités."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés aux aliments transgéniques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent éprouver des symptômes allergiques après consommation."
}
},
{
"@type": "Question",
"name": "Les transgènes peuvent-ils affecter la santé humaine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que certains transgènes peuvent avoir des impacts sur la santé."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux thérapies géniques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent entraîner des réactions comme de la fièvre ou des douleurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les risques liés aux transgènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réglementation stricte et les tests de sécurité sont essentiels pour prévenir les risques."
}
},
{
"@type": "Question",
"name": "Peut-on éviter les aliments transgéniques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en choisissant des produits bio ou en lisant les étiquettes des aliments."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité sont prises pour les transgènes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études de sécurité et des évaluations environnementales sont réalisées avant leur utilisation."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser sur les transgènes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des programmes éducatifs peuvent sensibiliser le public."
}
},
{
"@type": "Question",
"name": "Les organismes de réglementation surveillent-ils les transgènes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des organismes comme l'EFSA surveillent l'utilisation et la sécurité des transgènes."
}
},
{
"@type": "Question",
"name": "Comment les transgènes sont-ils utilisés en médecine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour développer des thérapies géniques pour traiter des maladies génétiques."
}
},
{
"@type": "Question",
"name": "Les transgènes peuvent-ils traiter des maladies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les transgènes sont utilisés pour traiter des maladies comme la fibrose kystique."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent des transgènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme la thérapie génique et les vaccins génétiquement modifiés en font partie."
}
},
{
"@type": "Question",
"name": "Les transgènes sont-ils utilisés en oncologie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont utilisés pour développer des traitements ciblés contre certains cancers."
}
},
{
"@type": "Question",
"name": "Quels sont les risques des traitements par transgènes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des réactions immunitaires et des effets secondaires imprévus."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les transgènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions allergiques et des effets à long terme non prévus."
}
},
{
"@type": "Question",
"name": "Les transgènes peuvent-ils causer des maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe des préoccupations sur le potentiel des transgènes à induire des maladies."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications environnementales liées aux transgènes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des impacts sur la biodiversité et des effets sur les écosystèmes sont possibles."
}
},
{
"@type": "Question",
"name": "Comment les transgènes affectent-ils la santé publique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent poser des risques pour la santé publique, nécessitant une surveillance continue."
}
},
{
"@type": "Question",
"name": "Les transgènes peuvent-ils affecter la reproduction ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que certains transgènes pourraient avoir des effets sur la reproduction."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les risques liés aux transgènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à des transgènes non réglementés et la consommation d'aliments non testés augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les allergies sont-elles un facteur de risque pour les transgènes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes allergiques peuvent avoir des réactions plus sévères aux aliments transgéniques."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans les risques des transgènes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions environnementales peuvent influencer l'impact des transgènes sur la santé."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils les risques liés aux transgènes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies ou de maladies auto-immunes peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les effets des transgènes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles aux effets des transgènes."
}
}
]
}
]
}
Kidney-type glutaminase (GLS1), a key enzyme controlling the hydrolysis of glutamine to glutamate to resolve the 'glutamine addiction' of cancer cells, has been shown to play a central role in support...
This review covers recent patents (2019-present) involving GLS1 inhibitors, which are mostly focused on their chemical structures, molecular mechanisms of action, pharmacokinetic properties, and poten...
Currently, despite significant efforts, the search for potent GLS1 inhibitors has not resulted in the development of compounds for therapeutic applications. Most recent patents and literature focus on...
Monoamine oxidase (MAO) inhibitors are currently used as antidepressants (selective MAO-A inhibitors) or as co-adjuvants for neurodegenerative diseases (selective MAO-B inhibitors). The research withi...
MAO inhibitors (2018-2021) are discussed according to their chemotypes. Structure-activity relationships are derived for each chemical scaffold (propargylamines, chalcones, indoles, benzimidazoles, (i...
MAO inhibitors here reported exhibit different potencies and isoform selectivity. These compounds are clinically licensed for multi-faceted neurodegenerative pathologies due to their ability to also a...
This paper studies the impact of the first joint licensing platform for patented drugs, the Medicines Patent Pool, on global drug diffusion and innovation. The pool allows generic firms worldwide to l...
The US has found it hard to establish competition in the market for biologics, which are therapeutics derived from living cells. In the case of small-molecule drugs, the emergence of direct competitio...
EZH2 is an important epigenetic regulator that forms the PRC2 complex with SUZ12, EED and RbAp46/48. As the key catalytic subunit of PRC2, EZH2 regulates the trimethylation of histone H3K27, which in ...
The aim of the present review is to provide an overview of the molecular mechanisms of EZH2 inhibitors and to highlight the research advances in the patent literature published from 2017 to date. A se...
In recent years, a great number of structurally diverse EZH2 inhibitors have been identified, including EZH2 reversible inhibitors, EZH2 irreversible inhibitors, EZH2-based dual inhibitors and EZH2 de...
Bromodomain and extraterminal (BET) proteins are epigenetic readers that regulate gene transcription and cell growth by binding to acetylated lysine residues on histones. They are involved in many phy...
This review aims at providing an overview of molecular mechanisms of BET inhibitors and highlighting the research advancements published in recent patent literatures between 2018 and 2021. Web of Scie...
In recent years, an increasing number of structurally diverse BET inhibitors have been identified, including pan BET inhibitors, BD1 or BD2 selective BET inhibitors, bivalent BET inhibitors, kinase an...
Lysine-specific demethylase 1 (LSD1), which belongs to the demethylase of non-histone proteins, is believed to promote cancer cell proliferation and metastasis by modifying histones. LSD1 dysfunction ...
This review summarizes the progress of LSD1 inhibitor research in the last four years, including selected new patents and article publications, as well as the therapeutic potential of these compounds....
Natural products offer a promising prospect for developing novel potent LSD1 inhibitors, as structural design and activity of irreversible and reversible inhibitors have been continuously optimized si...
This article examines discoveries, inventions, and innovations related to penicillin by sampling activities to solve technological problems which can be traced by the distribution of scientific articl...
Drug patent linkage is an important mechanism for the early resolution of patent disputes in the pharmaceutical field. Since its establishment in China in mid-2021, the patent linkage system has drawn...
Starting with the development of patent linkage in China, this paper provides an overview of the patent linkage system in connection with the first Abbreviated New Drug Application (ANDA) litigation i...
The legal framework and infrastructures required for the patent linkage system, including a platform for patent listing, patent certification, stay on generic approval, and first generic exclusivity, ...